Bausch Health
BHC
#4085
Rank
NZ$3.95 B
Marketcap
$10.75
Share price
-3.45%
Change (1 day)
-22.63%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.64. In 2022 the company made an earnings per share (EPS) of -$1.08 an increase over its 2021 EPS that were of -$4.64.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29295.75%
2022-$1.08-76.64%
2021-$4.6468.45%
2020-$2.75-68.91%
2019-$8.86-57.11%
2018-$20.65-272.22%
2017$11.99-199.29%
2016-$12.07798.7%
2015-$1.34-128.31%
2014$4.75-204.62%
2013-$4.54602.7%
2012-$0.65-171.15%
2011$0.91-143.96%
2010-$2.06-206.57%
2009$1.94-11.2%
2008$2.182.46%
2007$2.13-7.58%
2006$2.30-14.29%
2005$2.6954%
2004$1.74-500%
2003-$0.44-141.67%
2002$1.05-4.76%
2001$1.10-175%
2000-$1.47-268%
1999$0.8714.94%
1998$0.7620.83%
1997$0.6353.83%
1996$0.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.74-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA